{
    "abstract": "Background: Pertussis immunization during pregnancy results in high pertussis antibody concentrations in young infants but may interfere with infant immune responses to post-natal immunization. Methods: This phase IV, multi-country, open-label study assessed the immunogenicity and safety of infant primary vaccination with DTaP-HepB-IPV/Hib and 13-valent pneumococcal conjugate vaccine (PCV13). Enrolled infants (6\u201314 weeks old) were born to mothers who were randomized to receive reduced-antigen-content diphtheria-tetanus-three-component acellular pertussis vaccine (Tdap group) or placebo (control group) during pregnancy (270/7\u2013366/7 weeks\u2019 gestation) with crossover immunization postpartum. All infants received 2 or 3 DTaP-HepB-IPV/Hib and PCV13 doses according to national schedules. Immunogenicity was assessed in infants pre- and 1 month post-primary vaccination. The primary objective was to assess seroprotection/vaccine response rates for DTaP-HepB-IPV/Hib antigens 1 month post-primary vaccination. Results: 601 infants (Tdap group: 296; control group: 305) were vaccinated. One month post-priming, seroprotection rates were 100% (diphtheria; tetanus), \u226598.5% (hepatitis B), \u226595.9% (polio) and \u226594.5% (Hib) in both groups. Vaccine response rates for pertussis antigens were significantly lower in infants whose mothers received pregnancy Tdap (37.5\u201377.1%) versus placebo (90.0\u201399.2%). Solicited and unsolicited adverse event rates were similar between groups. Serious adverse events occurred in 2.4% (Tdap group) and 5.6% (control group) of infants, none were vaccination-related. Conclusions: Pertussis antibodies transferred during pregnancy may decrease the risk of pertussis infection in the first months of life but interfere with the infant's ability to produce pertussis antibodies, the clinical significance of which remains unknown. Safety and reactogenicity results were consistent with previous experience. Clinical Trial Registration: ClinicalTrials.gov: NCT02422264.",
    "author_highlights": [
        {
            "endOffset": 23335,
            "sentence": "Infants of mothers who participated in a phase IV maternal pertussis immunization trial (NCT02377349) received hexavalent DTaP and PCV13 primary series.",
            "startOffset": 23183
        },
        {
            "endOffset": 23474,
            "sentence": "High levels of maternally transferred pertussis antibodies persisted in infants from Tdap-vaccinated mothers until 2\u20133 months after birth.",
            "startOffset": 23336
        },
        {
            "endOffset": 23623,
            "sentence": "These maternally transferred pertussis antibodies interfered with the infant immune response to the pertussis components of the primary DTaP series.",
            "startOffset": 23475
        },
        {
            "endOffset": 23687,
            "sentence": "The clinical significance of this interference remains unknown.",
            "startOffset": 23624
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Cristina",
                    "initial": "C.",
                    "last": "Masseria"
                },
                {
                    "first": "Carolyn K.",
                    "initial": "C.K.",
                    "last": "Martin"
                },
                {
                    "first": "Girishanthy",
                    "initial": "G.",
                    "last": "Krishnarajah"
                },
                {
                    "first": "Laura K.",
                    "initial": "L.K.",
                    "last": "Becker"
                },
                {
                    "first": "Ami",
                    "initial": "A.",
                    "last": "Buikema"
                },
                {
                    "first": "Tina Q.",
                    "initial": "T.Q.",
                    "last": "Tan"
                }
            ],
            "doi": "10.1097/INF.0000000000001440",
            "firstpage": "e54",
            "issn": "08913668",
            "lastpage": "e61",
            "pmid": "27902648",
            "pub_year": 2017,
            "title": "Incidence and burden of pertussis among infants less than 1 year of age",
            "volume": "36"
        },
        "b0010": null,
        "b0015": {
            "authors": [],
            "firstpage": "433",
            "issn": "00498114",
            "lastpage": "458",
            "pmid": "26320265",
            "pub_year": 2015,
            "title": "Pertussis vaccines: WHO position paper - September 2015",
            "volume": "90"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Flor M.",
                    "initial": "F.M.",
                    "last": "Munoz"
                },
                {
                    "first": "Nanette H.",
                    "initial": "N.H.",
                    "last": "Bond"
                },
                {
                    "first": "Maurizio",
                    "initial": "M.",
                    "last": "Maccato"
                },
                {
                    "first": "Phillip",
                    "initial": "P.",
                    "last": "Pinell"
                },
                {
                    "first": "Hunter A.",
                    "initial": "H.A.",
                    "last": "Hammill"
                },
                {
                    "first": "Geeta K.",
                    "initial": "G.K.",
                    "last": "Swamy"
                },
                {
                    "first": "Emmanuel B.",
                    "initial": "E.B.",
                    "last": "Walter"
                },
                {
                    "first": "Lisa A.",
                    "initial": "L.A.",
                    "last": "Jackson"
                },
                {
                    "first": "Janet A.",
                    "initial": "J.A.",
                    "last": "Englund"
                },
                {
                    "first": "Morven S.",
                    "initial": "M.S.",
                    "last": "Edwards"
                },
                {
                    "first": "C. Mary",
                    "initial": "C.M.",
                    "last": "Healy"
                },
                {
                    "first": "Carey R.",
                    "initial": "C.R.",
                    "last": "Petrie"
                },
                {
                    "first": "Jennifer",
                    "initial": "J.",
                    "last": "Ferreira"
                },
                {
                    "first": "Johannes B.",
                    "initial": "J.B.",
                    "last": "Goll"
                },
                {
                    "first": "Carol J.",
                    "initial": "C.J.",
                    "last": "Baker"
                }
            ],
            "doi": "10.1001/jama.2014.3633",
            "firstpage": "1760",
            "issn": "00987484",
            "lastpage": "1769",
            "pmid": "24794369",
            "pub_year": 2014,
            "title": "Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: A randomized clinical trial",
            "volume": "311"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Ha Thi Thu",
                    "initial": "H.T.T.",
                    "last": "Hoang"
                },
                {
                    "first": "Elke",
                    "initial": "E.",
                    "last": "Leuridan"
                },
                {
                    "first": "Kirsten",
                    "initial": "K.",
                    "last": "Maertens"
                },
                {
                    "first": "Trung Dac",
                    "initial": "T.D.",
                    "last": "Nguyen"
                },
                {
                    "first": "Niel",
                    "initial": "N.",
                    "last": "Hens"
                },
                {
                    "first": "Ngoc Ha",
                    "initial": "N.H.",
                    "last": "Vu"
                },
                {
                    "first": "Raissa Nad\u00e8ge",
                    "initial": "R.N.",
                    "last": "Cabor\u00e9"
                },
                {
                    "first": "Hong Thi",
                    "initial": "H.T.",
                    "last": "Duong"
                },
                {
                    "first": "Kris",
                    "initial": "K.",
                    "last": "Huygen"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Van Damme"
                },
                {
                    "first": "Anh Duc",
                    "initial": "A.D.",
                    "last": "Dang"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.10.098",
            "firstpage": "151",
            "issn": "0264410X",
            "lastpage": "159",
            "pmid": "26529073",
            "pub_year": 2016,
            "title": "Pertussis vaccination during pregnancy in Vietnam: Results of a randomized controlled trial Pertussis vaccination during pregnancy",
            "volume": "34"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Jes\u00fas Zacar\u00edas",
                    "initial": "J.Z.",
                    "last": "Villarreal P\u00e9rez"
                },
                {
                    "first": "Jos\u00e9 Manuel",
                    "initial": "J.M.",
                    "last": "Ram\u00edrez Aranda"
                },
                {
                    "first": "Manuel",
                    "initial": "M.",
                    "last": "de la O Cavazos"
                },
                {
                    "first": "Michelle de J.",
                    "initial": "M.d.J.",
                    "last": "Zamudio Osuna"
                },
                {
                    "first": "Jos\u00e9",
                    "initial": "J.",
                    "last": "Perales D\u00e1vila"
                },
                {
                    "first": "Mar\u00eda Romelia",
                    "initial": "M.R.",
                    "last": "Ballesteros Elizondo"
                },
                {
                    "first": "Marco Vinicio",
                    "initial": "M.V.",
                    "last": "G\u00f3mez Meza"
                },
                {
                    "first": "Francisco Javier",
                    "initial": "F.J.",
                    "last": "Garc\u00eda Elizondo"
                },
                {
                    "first": "Azucena M.",
                    "initial": "A.M.",
                    "last": "Rodr\u00edguez Gonz\u00e1lez"
                }
            ],
            "doi": "10.1080/21645515.2016.1232786",
            "firstpage": "128",
            "issn": "21645515",
            "lastpage": "135",
            "pmid": "27686182",
            "pub_year": 2017,
            "title": "Randomized clinical trial of the safety and immunogenicity of the Tdap vaccine in pregnant Mexican women",
            "volume": "13"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Scott A.",
                    "initial": "S.A.",
                    "last": "Halperin"
                },
                {
                    "first": "Joanne M.",
                    "initial": "J.M.",
                    "last": "Langley"
                },
                {
                    "first": "Lingyun",
                    "initial": "L.",
                    "last": "Ye"
                },
                {
                    "first": "Donna",
                    "initial": "D.",
                    "last": "Mackinnon-Cameron"
                },
                {
                    "first": "May",
                    "initial": "M.",
                    "last": "Elsherif"
                },
                {
                    "first": "Victoria M.",
                    "initial": "V.M.",
                    "last": "Allen"
                },
                {
                    "first": "Bruce",
                    "initial": "B.",
                    "last": "Smith"
                },
                {
                    "first": "Beth A.",
                    "initial": "B.A.",
                    "last": "Halperin"
                },
                {
                    "first": "Shelly A.",
                    "initial": "S.A.",
                    "last": "McNeil"
                },
                {
                    "first": "Otto G.",
                    "initial": "O.G.",
                    "last": "Vanderkooi"
                },
                {
                    "first": "Shannon",
                    "initial": "S.",
                    "last": "Dwinnell"
                },
                {
                    "first": "R. Douglas",
                    "initial": "R.D.",
                    "last": "Wilson"
                },
                {
                    "first": "Bruce",
                    "initial": "B.",
                    "last": "Tapiero"
                },
                {
                    "first": "Marc",
                    "initial": "M.",
                    "last": "Boucher"
                },
                {
                    "first": "Nicole",
                    "initial": "N.",
                    "last": "Le Saux"
                },
                {
                    "first": "Andr\u00e9e",
                    "initial": "A.",
                    "last": "Gruslin"
                },
                {
                    "first": "Wendy",
                    "initial": "W.",
                    "last": "Vaudry"
                },
                {
                    "first": "Sue",
                    "initial": "S.",
                    "last": "Chandra"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "Dobson"
                },
                {
                    "first": "Deborah",
                    "initial": "D.",
                    "last": "Money"
                }
            ],
            "doi": "10.1093/cid/ciy244",
            "firstpage": "1063",
            "issn": "10584838",
            "lastpage": "1071",
            "pmid": "30010773",
            "pub_year": 2018,
            "title": "A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization during Pregnancy and Subsequent Infant Immune Response",
            "volume": "67"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Daan",
                    "initial": "D.",
                    "last": "Barug"
                },
                {
                    "first": "Inge",
                    "initial": "I.",
                    "last": "Pronk"
                },
                {
                    "first": "Marlies A.",
                    "initial": "M.A.",
                    "last": "van Houten"
                },
                {
                    "first": "Florens G.A.",
                    "initial": "F.G.A.",
                    "last": "Versteegh"
                },
                {
                    "first": "Mirjam J.",
                    "initial": "M.J.",
                    "last": "Knol"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "van de Kassteele"
                },
                {
                    "first": "Guy A.M.",
                    "initial": "G.A.M.",
                    "last": "Berbers"
                },
                {
                    "first": "Elisabeth A.M.",
                    "initial": "E.A.M.",
                    "last": "Sanders"
                },
                {
                    "first": "Nynke Y.",
                    "initial": "N.Y.",
                    "last": "Rots"
                }
            ],
            "doi": "10.1016/S1473-3099(18)30717-5",
            "firstpage": "392",
            "issn": "14733099",
            "lastpage": "401",
            "pmid": "30938299",
            "pub_year": 2019,
            "title": "Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial",
            "volume": "19"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Bahaa",
                    "initial": "B.",
                    "last": "Abu Raya"
                },
                {
                    "first": "Isaac",
                    "initial": "I.",
                    "last": "Srugo"
                },
                {
                    "first": "Aharon",
                    "initial": "A.",
                    "last": "Kessel"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Peterman"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Bader"
                },
                {
                    "first": "Ron",
                    "initial": "R.",
                    "last": "Gonen"
                },
                {
                    "first": "Ellen",
                    "initial": "E.",
                    "last": "Bamberger"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.08.038",
            "firstpage": "5787",
            "issn": "0264410X",
            "lastpage": "5793",
            "pmid": "25173476",
            "pub_year": 2014,
            "title": "The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - A prospective study",
            "volume": "32"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Kirsten",
                    "initial": "K.",
                    "last": "Maertens"
                },
                {
                    "first": "Ra\u00efssa Nad\u00e8ge",
                    "initial": "R.N.",
                    "last": "Cabor\u00e9"
                },
                {
                    "first": "Kris",
                    "initial": "K.",
                    "last": "Huygen"
                },
                {
                    "first": "Niel",
                    "initial": "N.",
                    "last": "Hens"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Van Damme"
                },
                {
                    "first": "Elke",
                    "initial": "E.",
                    "last": "Leuridan"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.10.100",
            "firstpage": "142",
            "issn": "0264410X",
            "lastpage": "150",
            "pmid": "26592142",
            "pub_year": 2016,
            "title": "Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study",
            "volume": "34"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Gayatri",
                    "initial": "G.",
                    "last": "Amirthalingam"
                },
                {
                    "first": "Nick",
                    "initial": "N.",
                    "last": "Andrews"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "Campbell"
                },
                {
                    "first": "Sonia",
                    "initial": "S.",
                    "last": "Ribeiro"
                },
                {
                    "first": "Edna",
                    "initial": "E.",
                    "last": "Kara"
                },
                {
                    "first": "Katherine",
                    "initial": "K.",
                    "last": "Donegan"
                },
                {
                    "first": "Norman K.",
                    "initial": "N.K.",
                    "last": "Fry"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Miller"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "Ramsay"
                }
            ],
            "doi": "10.1016/S0140-6736(14)60686-3",
            "firstpage": "1521",
            "issn": "01406736",
            "lastpage": "1528",
            "pmid": "25037990",
            "pub_year": 2014,
            "title": "Effectiveness of maternal pertussis vaccination in England: An observational study",
            "volume": "384"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Gavin",
                    "initial": "G.",
                    "last": "Dabrera"
                },
                {
                    "first": "Gayatri",
                    "initial": "G.",
                    "last": "Amirthalingam"
                },
                {
                    "first": "Nick",
                    "initial": "N.",
                    "last": "Andrews"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "Campbell"
                },
                {
                    "first": "Sonia",
                    "initial": "S.",
                    "last": "Ribeiro"
                },
                {
                    "first": "Edna",
                    "initial": "E.",
                    "last": "Kara"
                },
                {
                    "first": "Norman K.",
                    "initial": "N.K.",
                    "last": "Fry"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "Ramsay"
                }
            ],
            "doi": "10.1093/cid/ciu821",
            "firstpage": "333",
            "issn": "10584838",
            "lastpage": "337",
            "pmid": "25332078",
            "pub_year": 2015,
            "title": "A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012-2013",
            "volume": "60"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Gayatri",
                    "initial": "G.",
                    "last": "Amirthalingam"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "Campbell"
                },
                {
                    "first": "Sonia",
                    "initial": "S.",
                    "last": "Ribeiro"
                },
                {
                    "first": "Norman K.",
                    "initial": "N.K.",
                    "last": "Fry"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "Ramsay"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Miller"
                },
                {
                    "first": "Nick",
                    "initial": "N.",
                    "last": "Andrews"
                }
            ],
            "doi": "10.1093/cid/ciw559",
            "firstpage": "S236",
            "issn": "10584838",
            "lastpage": "S243",
            "pmid": "27838678",
            "pub_year": 2016,
            "title": "Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction",
            "volume": "63"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Roger",
                    "initial": "R.",
                    "last": "Baxter"
                },
                {
                    "first": "Joan",
                    "initial": "J.",
                    "last": "Bartlett"
                },
                {
                    "first": "Bruce",
                    "initial": "B.",
                    "last": "Fireman"
                },
                {
                    "first": "Edwin",
                    "initial": "E.",
                    "last": "Lewis"
                },
                {
                    "first": "Nicola P.",
                    "initial": "N.P.",
                    "last": "Klein"
                }
            ],
            "doi": "10.1542/peds.2016-4091",
            "issn": "00314005",
            "pmid": "28557752",
            "pub_year": 2017,
            "title": "Effectiveness of vaccination during pregnancy to prevent infant pertussis",
            "volume": "139"
        },
        "b0075": {
            "authors": [
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Bellido-Blasco"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Guiral-Rodrigo"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "M\u00edguez-Santiy\u00e1n"
                },
                {
                    "first": "Antonio",
                    "initial": "A.",
                    "last": "Salazar-Cifre"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Gonz\u00e1lez-Mor\u00e1n"
                }
            ],
            "doi": "10.2807/1560-7917.ES.2017.22.22.30545",
            "issn": "1025496X",
            "pmid": "28598324",
            "pub_year": 2017,
            "title": "A case\u2013control study to assess the effectiveness of pertussis vaccination during pregnancy on newborns, Valencian community, Spain, 1 March 2015 to 29 February 2016",
            "volume": "22"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Nathan",
                    "initial": "N.",
                    "last": "Saul"
                },
                {
                    "first": "Kevin",
                    "initial": "K.",
                    "last": "Wang"
                },
                {
                    "first": "Shopna",
                    "initial": "S.",
                    "last": "Bag"
                },
                {
                    "first": "Heather",
                    "initial": "H.",
                    "last": "Baldwin"
                },
                {
                    "first": "Kate",
                    "initial": "K.",
                    "last": "Alexander"
                },
                {
                    "first": "Meena",
                    "initial": "M.",
                    "last": "Chandra"
                },
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "Thomas"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "Quinn"
                },
                {
                    "first": "Vicky",
                    "initial": "V.",
                    "last": "Sheppeard"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Conaty"
                }
            ],
            "doi": "10.1016/j.vaccine.2018.02.047",
            "firstpage": "1887",
            "issn": "0264410X",
            "lastpage": "1892",
            "pmid": "29501321",
            "pub_year": 2018,
            "title": "Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case-control study",
            "volume": "36"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Tami H.",
                    "initial": "T.H.",
                    "last": "Skoff"
                },
                {
                    "first": "Amy E.",
                    "initial": "A.E.",
                    "last": "Blain"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Watt"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Scherzinger"
                },
                {
                    "first": "Melissa",
                    "initial": "M.",
                    "last": "McMahon"
                },
                {
                    "first": "Shelley M.",
                    "initial": "S.M.",
                    "last": "Zansky"
                },
                {
                    "first": "Kathy",
                    "initial": "K.",
                    "last": "Kudish"
                },
                {
                    "first": "Paul R.",
                    "initial": "P.R.",
                    "last": "Cieslak"
                },
                {
                    "first": "Melissa",
                    "initial": "M.",
                    "last": "Lewis"
                },
                {
                    "first": "Nong",
                    "initial": "N.",
                    "last": "Shang"
                },
                {
                    "first": "Stacey W.",
                    "initial": "S.W.",
                    "last": "Martin"
                }
            ],
            "doi": "10.1093/cid/cix724",
            "firstpage": "1977",
            "issn": "10584838",
            "lastpage": "1983",
            "pmid": "29028938",
            "pub_year": 2017,
            "title": "Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation",
            "volume": "65"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Eder Gatti",
                    "initial": "E.G.",
                    "last": "Fernandes"
                },
                {
                    "first": "Ana Paula S.",
                    "initial": "A.P.S.",
                    "last": "Sato"
                },
                {
                    "first": "Lourdes R.A.",
                    "initial": "L.R.A.",
                    "last": "Vaz-de-Lima"
                },
                {
                    "first": "Marcela",
                    "initial": "M.",
                    "last": "Rodrigues"
                },
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Leite"
                },
                {
                    "first": "Cyro A.",
                    "initial": "C.A.",
                    "last": "de Brito"
                },
                {
                    "first": "Expedito J.A.",
                    "initial": "E.J.A.",
                    "last": "Luna"
                },
                {
                    "first": "Telma Regina M.P.",
                    "initial": "T.R.M.P.",
                    "last": "Carvalhanas"
                },
                {
                    "first": "Maria L\u00edgia Bacciote Nerger",
                    "initial": "M.L.B.N.",
                    "last": "Ramos"
                },
                {
                    "first": "Helena Keico",
                    "initial": "H.K.",
                    "last": "Sato"
                },
                {
                    "first": "Euclides A.",
                    "initial": "E.A.",
                    "last": "de Castilho"
                }
            ],
            "doi": "10.1016/j.vaccine.2019.03.049",
            "firstpage": "5481",
            "issn": "0264410X",
            "lastpage": "5484",
            "pmid": "30948222",
            "pub_year": 2019,
            "title": "The effectiveness of maternal pertussis vaccination in protecting newborn infants in Brazil: A case-control study",
            "volume": "37"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Viviana",
                    "initial": "V.",
                    "last": "Romanin"
                },
                {
                    "first": "Anna M.",
                    "initial": "A.M.",
                    "last": "Acosta"
                },
                {
                    "first": "Maria Del Valle",
                    "initial": "M.D.V.",
                    "last": "Juarez"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Briere"
                },
                {
                    "first": "Stella Maris",
                    "initial": "S.M.",
                    "last": "Sanchez"
                },
                {
                    "first": "Beatriz Lopez",
                    "initial": "B.L.",
                    "last": "Cordoba"
                },
                {
                    "first": "Maria Eugenia",
                    "initial": "M.E.",
                    "last": "Sevilla"
                },
                {
                    "first": "Maria Florencia",
                    "initial": "M.F.",
                    "last": "Lucion"
                },
                {
                    "first": "Anahi",
                    "initial": "A.",
                    "last": "Urrutia"
                },
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Sagradini"
                },
                {
                    "first": "Tami H.",
                    "initial": "T.H.",
                    "last": "Skoff"
                },
                {
                    "first": "Carla",
                    "initial": "C.",
                    "last": "Vizzotti"
                }
            ],
            "doi": "10.1093/cid/ciz217",
            "firstpage": "380",
            "issn": "10584838",
            "lastpage": "387",
            "pmid": "30877308",
            "pub_year": 2020,
            "title": "Maternal vaccination in Argentina: Tetanus, diphtheria, and acellular pertussis vaccine effectiveness during pregnancy in preventing pertussis in infants <2 months of age",
            "volume": "70"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Abbey J.",
                    "initial": "A.J.",
                    "last": "Hardy-Fairbanks"
                },
                {
                    "first": "Stephanie J.",
                    "initial": "S.J.",
                    "last": "Pan"
                },
                {
                    "first": "Michael D.",
                    "initial": "M.D.",
                    "last": "Decker"
                },
                {
                    "first": "David R.",
                    "initial": "D.R.",
                    "last": "Johnson"
                },
                {
                    "first": "David P.",
                    "initial": "D.P.",
                    "last": "Greenberg"
                },
                {
                    "first": "Kathryn B.",
                    "initial": "K.B.",
                    "last": "Kirkland"
                },
                {
                    "first": "Elizabeth A.",
                    "initial": "E.A.",
                    "last": "Talbot"
                },
                {
                    "first": "Henry H.",
                    "initial": "H.H.",
                    "last": "Bernstein"
                }
            ],
            "doi": "10.1097/INF.0b013e3182a09b6a",
            "firstpage": "1257",
            "issn": "08913668",
            "lastpage": "1260",
            "pmid": "23799518",
            "pub_year": 2013,
            "title": "Immune responses in infants whose mothers received tdap vaccine during pregnancy",
            "volume": "32"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Shamez N.",
                    "initial": "S.N.",
                    "last": "Ladhani"
                },
                {
                    "first": "Nick J.",
                    "initial": "N.J.",
                    "last": "Andrews"
                },
                {
                    "first": "Jo",
                    "initial": "J.",
                    "last": "Southern"
                },
                {
                    "first": "Christine E.",
                    "initial": "C.E.",
                    "last": "Jones"
                },
                {
                    "first": "Gayatri",
                    "initial": "G.",
                    "last": "Amirthalingam"
                },
                {
                    "first": "Pauline A.",
                    "initial": "P.A.",
                    "last": "Waight"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "England"
                },
                {
                    "first": "Mary",
                    "initial": "M.",
                    "last": "Matheson"
                },
                {
                    "first": "Xilian",
                    "initial": "X.",
                    "last": "Bai"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "Findlow"
                },
                {
                    "first": "Polly",
                    "initial": "P.",
                    "last": "Burbidge"
                },
                {
                    "first": "Vasili",
                    "initial": "V.",
                    "last": "Thalasselis"
                },
                {
                    "first": "Bassam",
                    "initial": "B.",
                    "last": "Hallis"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Goldblatt"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                },
                {
                    "first": "Paul T.",
                    "initial": "P.T.",
                    "last": "Heath"
                },
                {
                    "first": "Elizabeth",
                    "initial": "E.",
                    "last": "Miller"
                }
            ],
            "doi": "10.1093/cid/civ695",
            "firstpage": "1637",
            "issn": "10584838",
            "lastpage": "1644",
            "pmid": "26374816",
            "pub_year": 2015,
            "title": "Antibody responses after primary immunization in infants born to women receiving a Pertussis-containing vaccine during pregnancy: Single arm observational study with a historical comparator",
            "volume": "61"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Kirsten",
                    "initial": "K.",
                    "last": "Maertens"
                },
                {
                    "first": "Thi Thu Ha",
                    "initial": "T.T.H.",
                    "last": "Hoang"
                },
                {
                    "first": "Trung Dac",
                    "initial": "T.D.",
                    "last": "Nguyen"
                },
                {
                    "first": "Ra\u00efssa Nad\u00e8ge",
                    "initial": "R.N.",
                    "last": "Cabor\u00e9"
                },
                {
                    "first": "Thi Hong",
                    "initial": "T.H.",
                    "last": "Duong"
                },
                {
                    "first": "Kris",
                    "initial": "K.",
                    "last": "Huygen"
                },
                {
                    "first": "Niel",
                    "initial": "N.",
                    "last": "Hens"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Van Damme"
                },
                {
                    "first": "Duc Anh",
                    "initial": "D.A.",
                    "last": "Dang"
                },
                {
                    "first": "Elke",
                    "initial": "E.",
                    "last": "Leuridan"
                }
            ],
            "doi": "10.1093/cid/ciw551",
            "firstpage": "S197",
            "issn": "10584838",
            "lastpage": "S204",
            "pmid": "27838673",
            "pub_year": 2016,
            "title": "The effect of maternal pertussis immunization on infant vaccine responses to a booster pertussis-containing vaccine in Vietnam",
            "volume": "63"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Ra\u00efssa Nad\u00e8ge",
                    "initial": "R.N.",
                    "last": "Cabor\u00e9"
                },
                {
                    "first": "Kirsten",
                    "initial": "K.",
                    "last": "Maertens"
                },
                {
                    "first": "Alexandre",
                    "initial": "A.",
                    "last": "Dobly"
                },
                {
                    "first": "Elke",
                    "initial": "E.",
                    "last": "Leuridan"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Van Damme"
                },
                {
                    "first": "Kris",
                    "initial": "K.",
                    "last": "Huygen"
                }
            ],
            "doi": "10.1080/21505594.2017.1296998",
            "firstpage": "1245",
            "issn": "21505594",
            "lastpage": "1254",
            "pmid": "28277900",
            "pub_year": 2017,
            "title": "Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium",
            "volume": "8"
        },
        "b0120": null,
        "b0125": {
            "authors": [
                {
                    "first": "Moira E.",
                    "initial": "M.E.",
                    "last": "Melville-Smith"
                },
                {
                    "first": "Valerie A.",
                    "initial": "V.A.",
                    "last": "Seagroatt"
                },
                {
                    "first": "Johanna T.",
                    "initial": "J.T.",
                    "last": "Watkins"
                }
            ],
            "doi": "10.1016/S0092-1157(83)80038-9",
            "firstpage": "137",
            "issn": "00921157",
            "lastpage": "144",
            "pmid": "6345548",
            "pub_year": 1983,
            "title": "A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera",
            "volume": "11"
        },
        "b0130": {
            "authors": [
                {
                    "first": "M. E.",
                    "initial": "M.E.",
                    "last": "Camargo"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Silveira"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Furuta"
                },
                {
                    "first": "E. P.",
                    "initial": "E.P.",
                    "last": "Oliveira"
                },
                {
                    "first": "O. A.",
                    "initial": "O.A.",
                    "last": "Germek"
                }
            ],
            "doi": "10.1128/jcm.20.4.772-774.1984",
            "firstpage": "772",
            "issn": "00951137",
            "lastpage": "774",
            "pmid": "6386879",
            "pub_year": 1984,
            "title": "Immunoenzymatic assay of anti-diphtheric toxin antibodies in human serum",
            "volume": "20"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Stanley A.",
                    "initial": "S.A.",
                    "last": "Plotkin"
                }
            ],
            "doi": "10.1128/CVI.00131-10",
            "firstpage": "1055",
            "issn": "15566811",
            "lastpage": "1065",
            "pmid": "20463105",
            "pub_year": 2010,
            "title": "Correlates of protection induced by vaccination",
            "volume": "17"
        },
        "b0140": {
            "authors": [],
            "firstpage": "1",
            "issn": "10575987",
            "lastpage": "25",
            "pmid": "1835756",
            "pub_year": 1991,
            "title": "Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP).",
            "volume": "40"
        },
        "b0145": {
            "authors": [
                {
                    "first": "A. D.",
                    "initial": "A.D.",
                    "last": "Jack"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Hall"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Maine"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Mendy"
                },
                {
                    "first": "H. C.",
                    "initial": "H.C.",
                    "last": "Whittle"
                }
            ],
            "doi": "10.1086/314578",
            "firstpage": "489",
            "issn": "00221899",
            "lastpage": "492",
            "pmid": "9878036",
            "pub_year": 1999,
            "title": "What level of hepatitis B antibody is protective?",
            "volume": "179"
        },
        "b0150": null,
        "b0155": {
            "authors": [
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Kayhty"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Peltola"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Karanko"
                },
                {
                    "first": "P. H.",
                    "initial": "P.H.",
                    "last": "Makela"
                }
            ],
            "doi": "10.1093/infdis/147.6.1100",
            "firstpage": "1100",
            "issn": "00221899",
            "pmid": "6602191",
            "pub_year": 1983,
            "title": "The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b",
            "volume": "147"
        },
        "b0160": {
            "authors": [
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Anderson"
                }
            ],
            "firstpage": "1034",
            "issn": "00221899",
            "lastpage": "1035",
            "pmid": "6610714",
            "pub_year": 1984,
            "title": "The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.",
            "volume": "149"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Muriel",
                    "initial": "M.",
                    "last": "Feyssaguet"
                },
                {
                    "first": "Aur\u00e9lie",
                    "initial": "A.",
                    "last": "Bellanger"
                },
                {
                    "first": "Florence",
                    "initial": "F.",
                    "last": "Nozay"
                },
                {
                    "first": "Damien",
                    "initial": "D.",
                    "last": "Friel"
                },
                {
                    "first": "Estelle",
                    "initial": "E.",
                    "last": "Merck"
                },
                {
                    "first": "Vincent",
                    "initial": "V.",
                    "last": "Verlant"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Malev\u00e9"
                },
                {
                    "first": "St\u00e9phane",
                    "initial": "S.",
                    "last": "Lallemand"
                },
                {
                    "first": "Abdelkarim",
                    "initial": "A.",
                    "last": "El Moussaoui"
                },
                {
                    "first": "Polly",
                    "initial": "P.",
                    "last": "De Gorguette D'Argoeuves"
                },
                {
                    "first": "Tessa",
                    "initial": "T.",
                    "last": "Jones"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Goldblatt"
                },
                {
                    "first": "Sonia",
                    "initial": "S.",
                    "last": "Schoonbroodt"
                }
            ],
            "doi": "10.1016/j.vaccine.2019.03.011",
            "firstpage": "2208",
            "issn": "0264410X",
            "lastpage": "2215",
            "pmid": "30879829",
            "pub_year": 2019,
            "title": "Comparison between a new multiplex electrochemiluminescence assay and the WHO reference enzyme-linked immunosorbent assay to measure serum antibodies against pneumococcal serotype-specific polysaccharides",
            "volume": "37"
        },
        "b0170": {
            "authors": [
                {
                    "first": "George R.",
                    "initial": "G.R.",
                    "last": "Siber"
                },
                {
                    "first": "Ih",
                    "initial": "I.",
                    "last": "Chang"
                },
                {
                    "first": "Sherryl",
                    "initial": "S.",
                    "last": "Baker"
                },
                {
                    "first": "Philip",
                    "initial": "P.",
                    "last": "Fernsten"
                },
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                },
                {
                    "first": "Mathuram",
                    "initial": "M.",
                    "last": "Santosham"
                },
                {
                    "first": "Keith P.",
                    "initial": "K.P.",
                    "last": "Klugman"
                },
                {
                    "first": "Shabir A.",
                    "initial": "S.A.",
                    "last": "Madhi"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Paradiso"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Kohberger"
                }
            ],
            "doi": "10.1016/j.vaccine.2007.01.119",
            "firstpage": "3816",
            "issn": "0264410X",
            "lastpage": "3826",
            "pmid": "17368878",
            "pub_year": 2007,
            "title": "Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies",
            "volume": "25"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Kathryn M.",
                    "initial": "K.M.",
                    "last": "Edwards"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.07.085",
            "firstpage": "6469",
            "issn": "0264410X",
            "lastpage": "6472",
            "pmid": "26256526",
            "pub_year": 2015,
            "title": "Maternal antibodies and infant immune responses to vaccines",
            "volume": "33"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Stefan",
                    "initial": "S.",
                    "last": "Niewiesk"
                }
            ],
            "doi": "10.3389/fimmu.2014.00446",
            "issn": "16643224",
            "pub_year": 2014,
            "title": "Maternal antibodies: Clinical significance, mechanism of interference with immune responses, and possible vaccination strategies",
            "volume": "5"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Kirsten",
                    "initial": "K.",
                    "last": "Maertens"
                },
                {
                    "first": "Polly",
                    "initial": "P.",
                    "last": "Burbidge"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "van Damme"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Goldblatt"
                },
                {
                    "first": "Elke",
                    "initial": "E.",
                    "last": "Leuridan"
                }
            ],
            "doi": "10.1097/INF.0000000000001601",
            "issn": "08913668",
            "pmid": "28399054",
            "pub_year": 2017,
            "title": "Pneumococcal Immune Response in Infants Whose Mothers Received Tdap Vaccination During Pregnancy"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Merryn",
                    "initial": "M.",
                    "last": "Voysey"
                },
                {
                    "first": "Dominic F.",
                    "initial": "D.F.",
                    "last": "Kelly"
                },
                {
                    "first": "Thomas R.",
                    "initial": "T.R.",
                    "last": "Fanshawe"
                },
                {
                    "first": "Manish",
                    "initial": "M.",
                    "last": "Sadarangani"
                },
                {
                    "first": "Katherine L.",
                    "initial": "K.L.",
                    "last": "O'Brien"
                },
                {
                    "first": "Rafael",
                    "initial": "R.",
                    "last": "Perera"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Pollard"
                }
            ],
            "doi": "10.1001/jamapediatrics.2017.0638",
            "firstpage": "637",
            "issn": "21686203",
            "lastpage": "646",
            "pmid": "28505244",
            "pub_year": 2017,
            "title": "The influence of maternally derived antibody and infant age at vaccination on infant vaccine responses: An individual participant meta-analysis",
            "volume": "171"
        },
        "b0195": {
            "authors": [
                {
                    "first": "Sylvia",
                    "initial": "S.",
                    "last": "Becker-Dreps"
                },
                {
                    "first": "Anne M.",
                    "initial": "A.M.",
                    "last": "Butler"
                },
                {
                    "first": "Leah J.",
                    "initial": "L.J.",
                    "last": "McGrath"
                },
                {
                    "first": "Kim A.",
                    "initial": "K.A.",
                    "last": "Boggess"
                },
                {
                    "first": "David J.",
                    "initial": "D.J.",
                    "last": "Weber"
                },
                {
                    "first": "Dongmei",
                    "initial": "D.",
                    "last": "Li"
                },
                {
                    "first": "Michael G.",
                    "initial": "M.G.",
                    "last": "Hudgens"
                },
                {
                    "first": "J. Bradley",
                    "initial": "J.B.",
                    "last": "Layton"
                }
            ],
            "doi": "10.1016/j.amepre.2018.04.013",
            "firstpage": "159",
            "issn": "07493797",
            "lastpage": "166",
            "pmid": "29910115",
            "pub_year": 2018,
            "title": "Effectiveness of Prenatal Tetanus, Diphtheria, Acellular Pertussis Vaccination in the Prevention of Infant Pertussis in the U.S.",
            "volume": "55"
        }
    },
    "body_text": [
        {
            "endOffset": 37183,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "601 infants were enrolled and included in the TVC: 296 whose mothers were randomized to receive Tdap (Tdap group) and 305 whose mothers were randomized to receive placebo (control group) during pregnancy in the maternal immunization trial.",
            "startOffset": 36944,
            "title": "Study population"
        },
        {
            "endOffset": 30382,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Infants received 2 or 3 doses of DTaP-HepB-IPV/Hib (Infanrix Hexa, GSK) co-administered with PCV13 (Prevnar 13, Pfizer Inc.) at 2 and 4 months; or 3 and 5 months; or 2, 4 and 6 months; or 2, 3 and 4 months of age, according to the different countries\u2019 routine primary immunization schedules (Fig. 1).",
            "startOffset": 30082,
            "title": "Procedures"
        },
        {
            "endOffset": 40583,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Solicited AEs were reported at similar rates in both groups, with redness being the most commonly reported local AE at the DTaP-HepB-IPV/Hib and PCV13 injection sites (Table 6) and irritability the most commonly reported general AE (Table 6).",
            "startOffset": 40341,
            "title": "Reactogenicity and safety"
        },
        {
            "endOffset": 37300,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "592 infants (98.5%) completed the study and 542 (90.2%) were included in the ATP cohort for immunogenicity (Fig. 2).",
            "startOffset": 37184,
            "title": "Study population"
        },
        {
            "endOffset": 33110,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "At each vaccination visit, the infants\u2019 parents or legally acceptable representatives (LARs) received diary cards to record solicited local (injection site pain, redness, swelling) and general (drowsiness, irritability, loss of appetite, fever) adverse events (AEs) within 4 days and unsolicited AEs within 31 days after each vaccination.",
            "startOffset": 32772,
            "title": "Procedures"
        },
        {
            "endOffset": 36839,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 36741,
                    "startOffset": 36737
                }
            },
            "secId": "s0030",
            "sentence": "Congenital anomalies which became apparent once the maternal immunization trial [24] ended were reported as pre-existing medical condition in the present study and analyzed post-hoc.",
            "startOffset": 36657,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 28917,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 28916,
                    "startOffset": 28912
                }
            },
            "secId": "s0015",
            "sentence": "We enrolled healthy infants 6\u201314 weeks old whose mothers had participated in a phase IV, observer-blind, randomized, placebo-controlled maternal immunization trial (NCT02377349) in which they received reduced-antigen-content Tdap vaccine or placebo at 270/7\u2013366/7 weeks\u2019 gestation and crossover administration within 72 h postpartum [24].",
            "startOffset": 28579,
            "title": "Study design and participants"
        },
        {
            "endOffset": 31057,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Blood samples were collected before the first DTaP-HepB-IPV/Hib dose (2 mL, pre-primary) and 1 month (allowed interval: 21\u201348 days) after the last DTaP-HepB-IPV/Hib dose (5 mL, post-primary) (Fig. 1).",
            "startOffset": 30857,
            "title": "Procedures"
        },
        {
            "endOffset": 47430,
            "parents": [],
            "secId": "s0075",
            "sentence": "Hence, the results may not be generalizable to low- and middle- income countries, to infants of other ethnic groups or infants born from high-risk pregnancies.",
            "startOffset": 47271,
            "title": "Discussion"
        },
        {
            "endOffset": 46262,
            "parents": [],
            "secId": "s0075",
            "sentence": "Importantly, the clinical relevance of the lower post-primary antibody levels in infants from Tdap-vaccinated mothers remains unknown, since there is no established correlate of protection for pertussis.",
            "startOffset": 46059,
            "title": "Discussion"
        },
        {
            "endOffset": 44831,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 44830,
                    "startOffset": 44826
                }
            },
            "secId": "s0075",
            "sentence": "Maternal antibody interference with the immune response to infant vaccination has also been described as a natural phenomenon in the absence of maternal immunization in a recent meta-analysis of 32 clinical trials [38].",
            "startOffset": 44612,
            "title": "Discussion"
        },
        {
            "endOffset": 30599,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "DTaP-HepB-IPV/Hib and PCV13 were injected intramuscularly in opposite thighs.",
            "startOffset": 30522,
            "title": "Procedures"
        },
        {
            "endOffset": 46059,
            "parents": [],
            "secId": "s0075",
            "sentence": "In our subgroup analysis by dose schedule, nearly all infants in the 2-dose subgroup started their primary series at 3 months of age; interference with the pertussis response seemed to occur in this subgroup as well; however, the small sample size of this subgroup precludes any sound conclusions.",
            "startOffset": 45762,
            "title": "Discussion"
        },
        {
            "endOffset": 47792,
            "parents": [],
            "secId": "s0075",
            "sentence": "Because mothers in the control group received Tdap postpartum, antibodies to Tdap antigens might have been transferred through breast milk to infants in the control group.",
            "startOffset": 47621,
            "title": "Discussion"
        },
        {
            "endOffset": 33298,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Diary cards were returned at the next visit, during which the investigators asked the parents/LARs about any other possible AEs (or serious AEs [SAEs]) occurring since the previous visit.",
            "startOffset": 33111,
            "title": "Procedures"
        },
        {
            "endOffset": 47620,
            "parents": [],
            "secId": "s0075",
            "sentence": "We also did not assess the effect of breastfeeding on antibody levels before and after the infant primary series.",
            "startOffset": 47507,
            "title": "Discussion"
        },
        {
            "endOffset": 28333,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The trial (ClinicalTrials.gov: NCT02422264) was performed according to the principles of Good Clinical Practice, the Declaration of Helsinki and applicable regulations.",
            "startOffset": 28165,
            "title": "Study design and participants"
        },
        {
            "endOffset": 40786,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Unsolicited AEs were reported for 54.4% and 56.7% of infants in the Tdap and control groups, respectively, most being mild or moderate (Table 6).",
            "startOffset": 40641,
            "title": "Reactogenicity and safety"
        },
        {
            "endOffset": 49336,
            "parents": [],
            "secId": "s0080",
            "sentence": "The reactogenicity and safety of DTaP-HepB-IPV/Hib and PCV13 in infants did not seem impacted by whether their mothers received Tdap or placebo during pregnancy.",
            "startOffset": 49175,
            "title": "Conclusion"
        },
        {
            "endOffset": 49723,
            "parents": [],
            "secId": "s0085",
            "sentence": "BC, FMT, JMMA, LK, MAC, MV, NMes, NMey, PGM, SAH, SOK, TN and ZS were involved in data analysis and interpretation.",
            "startOffset": 49608,
            "title": "Contributors"
        },
        {
            "endOffset": 26795,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 26730,
                    "startOffset": 26727
                }
            },
            "secId": "s0005",
            "sentence": "Several strategies to optimize pertussis control and protection during this susceptible period were pursued [3]; vaccination of pregnant women is the most commonly implemented.",
            "startOffset": 26619,
            "title": "Introduction"
        },
        {
            "endOffset": 29615,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The parent(s) or legally acceptable representative(s) of each participant provided written informed consent before enrollment.",
            "startOffset": 29489,
            "title": "Study design and participants"
        },
        {
            "endOffset": 36116,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Geometric mean antibody concentrations and titers (GMCs and GMTs) were calculated with 95% CIs by taking the anti-log of the mean of the log10 concentration or titer transformations.",
            "startOffset": 35934,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 39633,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0060",
            "sentence": "Before the first primary dose (i.e., at 2 or 3 months of age depending on the schedule the infant received), more infants in the Tdap group were seroprotected against diphtheria (82.6% in Tdap vs 43.7% in control); against tetanus (99.2% in Tdap vs 88.9% in control); and also more were seropositive for the three pertussis antigens (90.1%\u2013100% in Tdap vs 34.8%\u201383.0% in control) (Table 5).",
            "startOffset": 39243,
            "title": "Persistence of maternally transferred antibodies to Tdap antigens"
        },
        {
            "endOffset": 49446,
            "parents": [],
            "secId": "s0085",
            "sentence": "ACM, BC, FOT, JTRA, KPP, NMes, OGV, SAH, SOK and TN were involved in study conception and design.",
            "startOffset": 49349,
            "title": "Contributors"
        },
        {
            "endOffset": 35933,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Seroprotection, seropositivity and vaccine response rates were calculated with exact 95% confidence intervals (CIs).",
            "startOffset": 35817,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 42092,
            "parents": [],
            "secId": "s0075",
            "sentence": "The key rationale for pertussis immunization during pregnancy is to protect infants too young to be vaccinated from pertussis disease and death by achieving persistent high levels of maternally transferred pertussis antibodies in infants between birth and the first primary immunization dose.",
            "startOffset": 41800,
            "title": "Discussion"
        },
        {
            "endOffset": 43658,
            "parents": [],
            "refoffsets": {
                "b0175": {
                    "endOffset": 43588,
                    "startOffset": 43581
                },
                "b0180": {
                    "endOffset": 43588,
                    "startOffset": 43581
                }
            },
            "secId": "s0075",
            "sentence": "The concept of immune interference or blunting, where maternal antibodies reduce antibody generation to the infant primary series [35,36], resulting in lower post-primary antibody concentrations, is not new.",
            "startOffset": 43451,
            "title": "Discussion"
        },
        {
            "endOffset": 30521,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "In some countries/regions with a 3-dose primary DTaP-HepB-IPV/Hib schedule, PCV13 was given as a 2-dose schedule at 2 and 4 months of age.",
            "startOffset": 30383,
            "title": "Procedures"
        },
        {
            "endOffset": 48158,
            "parents": [],
            "secId": "s0075",
            "sentence": "A follow-up study is ongoing in the same infant cohort to investigate the effect of maternal Tdap immunization on the persistence of antibodies induced by the primary DTaP-HepB-IPV/Hib and PCV13 series up to 11\u201318 months of age and the effect on the immune response to booster DTaP-HepB-IPV/Hib and PCV13 vaccination in the child\u2019s second year of life (NCT02853929).",
            "startOffset": 47792,
            "title": "Discussion"
        },
        {
            "endOffset": 32712,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0165": {
                    "endOffset": 32711,
                    "startOffset": 32704
                },
                "b0170": {
                    "endOffset": 32711,
                    "startOffset": 32704
                }
            },
            "secId": "s0020",
            "sentence": "A threshold of 0.35 \u00b5g/mL for the ECL assays was shown to be equivalent to the 0.35 \u00b5g/mL PCV licensure threshold established for the World Health Organization pneumococcal reference ELISA [33,34].",
            "startOffset": 32515,
            "title": "Procedures"
        },
        {
            "endOffset": 27919,
            "parents": [],
            "secId": "s0005",
            "sentence": "We evaluated the immunogenicity and safety of a childhood hexavalent diphtheria-tetanus-three-component acellular pertussis-hepatitis B virus-poliovirus and Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (DTaP-HepB-IPV/Hib) co-administered with the 13-valent pneumococcal conjugate vaccine (PCV13) in infants born to mothers given reduced-antigen-content Tdap vaccine during pregnancy or postpartum.",
            "startOffset": 27504,
            "title": "Introduction"
        },
        {
            "endOffset": 36657,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "SAEs were described in detail.",
            "startOffset": 36627,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 40212,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0065",
            "sentence": "Generally, the trends we described for the overall population were observed for both schedules (Supplementary tables 1\u20133).",
            "startOffset": 40090,
            "title": "Subgroup analysis by dose schedule"
        },
        {
            "endOffset": 46741,
            "parents": [],
            "secId": "s0075",
            "sentence": "This study provides further evidence of the tolerability and safety of DTaP-HepB-IPV/Hib and PCV13 in infants whose mothers received Tdap vaccine during pregnancy.",
            "startOffset": 46578,
            "title": "Discussion"
        },
        {
            "endOffset": 45232,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 45231,
                    "startOffset": 45227
                }
            },
            "secId": "s0075",
            "sentence": "Two-fold higher maternal antibody levels were estimated to result in 11% lower post-vaccination antibody levels for PT and FHA, 22% lower for PRN, 13% lower for tetanus and 24% lower for diphtheria [38].",
            "startOffset": 45029,
            "title": "Discussion"
        },
        {
            "endOffset": 33604,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The total safety follow-up time depended on the vaccination schedule: approximately 5 months for infants receiving a 3-dose schedule at 2, 4 and 6 months of age and approximately 3 months for infants receiving the other schedules.",
            "startOffset": 33374,
            "title": "Procedures"
        },
        {
            "endOffset": 34050,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The primary objective was to assess the immune response to DTaP-HepB-IPV/Hib in terms of anti-diphtheria, anti-tetanus, anti-HBs, anti-poliovirus types 1\u20133 and anti-PRP seroprotection; and anti-FHA, anti-PRN and anti-PT vaccine responses 1 month post-primary vaccination.",
            "startOffset": 33779,
            "title": "Objectives"
        },
        {
            "endOffset": 42580,
            "parents": [],
            "secId": "s0075",
            "sentence": "Infants of Tdap-immunized mothers presented significantly higher antibody levels for all Tdap antigens before the primary series compared to infants of control mothers.",
            "startOffset": 42412,
            "title": "Discussion"
        },
        {
            "endOffset": 48908,
            "parents": [],
            "secId": "s0080",
            "sentence": "Ongoing epidemiological surveillance of the maternal immunization strategy is required to further understand if there is a clinical impact.",
            "startOffset": 48769,
            "title": "Conclusion"
        },
        {
            "endOffset": 34365,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Vaccine response was defined as a post-vaccination antibody concentration at least as high as the LLoQ for infants with a pre-vaccination concentration <LLoQ; and a post-vaccination antibody concentration at least as high as the pre-vaccination concentration for infants with a pre-vaccination concentration \u2265LLoQ.",
            "startOffset": 34051,
            "title": "Objectives"
        },
        {
            "endOffset": 29411,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Exclusion criteria included a history of diphtheria, tetanus, pertussis, hepatitis B, polio, Hib or pneumococcal diseases; vaccination against any of these diseases since birth (except hepatitis B vaccination); administration of long-acting immune-modifying drugs, any chronic drug therapy or immunoglobulins and/or blood products; and immunosuppressive conditions.",
            "startOffset": 29046,
            "title": "Study design and participants"
        },
        {
            "endOffset": 43286,
            "parents": [],
            "refoffsets": {
                "b0165": {
                    "endOffset": 43284,
                    "startOffset": 43277
                },
                "b0170": {
                    "endOffset": 43284,
                    "startOffset": 43277
                }
            },
            "secId": "s0075",
            "sentence": "Likewise, we observed no interference with the response to PCV13 in terms of percentages of infants achieving the 0.35 \u00b5g/mL threshold (shown to be equivalent to the threshold used for PCV licensure [33,34]).",
            "startOffset": 43078,
            "title": "Discussion"
        },
        {
            "endOffset": 36626,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Percentages of participants for whom solicited or unsolicited AEs were reported were calculated with exact 95% CIs.",
            "startOffset": 36511,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 36917,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Analyses were performed using SAS version 9.2.",
            "startOffset": 36871,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 38963,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0055",
            "sentence": "One month post-primary vaccination, the percentages of infants with serotype-specific anti-pneumococcal antibody concentrations \u22650.35 \u00b5g/mL were similar in both groups for each PCV13 serotype (Table 4).",
            "startOffset": 38761,
            "title": "Response to the PCV13 primary series"
        },
        {
            "endOffset": 38720,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0050",
            "sentence": "For the other DTaP-HepB-IPV/Hib antigens, antibody GMCs were similar between the two groups (Table 2).",
            "startOffset": 38618,
            "title": "Response to the DTaP-HepB-IPV/Hib primary series"
        },
        {
            "endOffset": 38617,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0050",
            "sentence": "Post-primary anti-diphtheria antibody GMCs were also lower in the Tdap than in the control group.",
            "startOffset": 38520,
            "title": "Response to the DTaP-HepB-IPV/Hib primary series"
        },
        {
            "endOffset": 42847,
            "parents": [],
            "secId": "s0075",
            "sentence": "However, immunological interference was evident for pertussis (in terms of GMCs and vaccine response rates) and to a lesser extent for diphtheria (in terms of GMC but not seroprotection rate) after the primary DTaP-HBV-IPV/Hib series in infants born to Tdap mothers.",
            "startOffset": 42581,
            "title": "Discussion"
        },
        {
            "endOffset": 41789,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Supplementary Fig. 1 depicts a plain language summary outlining the findings and highlighting their clinical relevance.",
            "startOffset": 41670,
            "title": "Reactogenicity and safety"
        },
        {
            "endOffset": 34648,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Because of the expected decline in maternally transferred pertussis antibodies between the pre- and post-vaccination time points, a post-vaccination concentration equal to the pre-vaccination concentration would correspond to at least a 2-fold increase in infant-induced antibodies.",
            "startOffset": 34366,
            "title": "Objectives"
        },
        {
            "endOffset": 42411,
            "parents": [],
            "secId": "s0075",
            "sentence": "Our study\u2014the largest RCT to date to investigate this\u2014showed that administration of the reduced-antigen-content Tdap vaccine during the third trimester of pregnancy resulted in high levels of maternally transferred pertussis antibodies in infants up to the pre-primary vaccination time point (at 2 or 3 months of age).",
            "startOffset": 42093,
            "title": "Discussion"
        },
        {
            "endOffset": 29045,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Infants born prematurely (<37 weeks\u2019 gestation, but after 27 weeks\u2019 gestation) could be enrolled if they were medically stable.",
            "startOffset": 28918,
            "title": "Study design and participants"
        },
        {
            "endOffset": 46809,
            "parents": [],
            "secId": "s0075",
            "sentence": "Rates of solicited and unsolicited AEs were similar between groups.",
            "startOffset": 46742,
            "title": "Discussion"
        },
        {
            "endOffset": 37375,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Baseline characteristics were comparable between the two groups (Table 1).",
            "startOffset": 37301,
            "title": "Study population"
        },
        {
            "endOffset": 40914,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Upper respiratory tract infection was the most common unsolicited AE (Tdap: 12.2%, 95% CI: 8.7\u201316.4; control: 10.8%, 7.6\u201314.9).",
            "startOffset": 40787,
            "title": "Reactogenicity and safety"
        },
        {
            "endOffset": 41031,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Nine SAEs were reported for seven (2.4%) infants in the Tdap group and 23 for 17 (5.6%) infants in the control group.",
            "startOffset": 40914,
            "title": "Reactogenicity and safety"
        },
        {
            "endOffset": 35304,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The reactogenicity and safety of DTaP-HepB-IPV/Hib and PCV13 primary vaccination were assessed as secondary objective in terms of the occurrence of solicited AEs, unsolicited AEs and SAEs.",
            "startOffset": 35116,
            "title": "Objectives"
        },
        {
            "endOffset": 31500,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Antibodies against diphtheria, tetanus and the three pertussis antigens (filamentous hemagglutinin [FHA], pertactin [PRN] and pertussis toxoid [PT]) were measured using validated enzyme-linked immunosorbent assays (ELISAs), with assay cut-offs (lower limits of quantitation [LLoQs]) of 0.057 IU/mL (anti-diphtheria), 0.043 IU/mL (anti-tetanus), 2.046 IU/mL (anti-FHA), 2.187 IU/mL (anti-PRN) and 2.693 IU/mL (anti-PT) defining seropositivity.",
            "startOffset": 31058,
            "title": "Procedures"
        },
        {
            "endOffset": 36258,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Antibody concentrations or titers below the assay cut-offs were given arbitrary values of half the cut-offs for the GMC and GMT calculations.",
            "startOffset": 36117,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 29488,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The Supplementary methods provide detailed inclusion and exclusion criteria.",
            "startOffset": 29412,
            "title": "Study design and participants"
        },
        {
            "endOffset": 30857,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The composition of both vaccines is provided in the Supplementary methods.",
            "startOffset": 30783,
            "title": "Procedures"
        },
        {
            "endOffset": 41670,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Congenital anomalies were reported for 24 (8.1%, 95% CI: 5.3\u201311.8) infants from Tdap-vaccinated mothers and 28 (9.2%, 6.2\u201313.0) infants from control mothers, atrial septal defect being most common (Tdap: 1.4%, 0.4\u20133.4; control: 2.6%, 1.1\u20135.1).",
            "startOffset": 41427,
            "title": "Reactogenicity and safety"
        },
        {
            "endOffset": 46535,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 46534,
                    "startOffset": 46524
                },
                "b0070": {
                    "endOffset": 46534,
                    "startOffset": 46524
                },
                "b0195": {
                    "endOffset": 46534,
                    "startOffset": 46524
                }
            },
            "secId": "s0075",
            "sentence": "To date, there is no evidence that the observed immunological interference is of clinical significance as there has been no increase in pertussis disease in infants born to Tdap-vaccinated mothers following primary series vaccinations in the first year of life [13,14,39].",
            "startOffset": 46263,
            "title": "Discussion"
        },
        {
            "endOffset": 44385,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 44384,
                    "startOffset": 44367
                },
                "b0025": {
                    "endOffset": 44384,
                    "startOffset": 44367
                },
                "b0050": {
                    "endOffset": 44384,
                    "startOffset": 44367
                },
                "b0105": {
                    "endOffset": 44384,
                    "startOffset": 44367
                },
                "b0110": {
                    "endOffset": 44384,
                    "startOffset": 44367
                },
                "b0185": {
                    "endOffset": 44384,
                    "startOffset": 44367
                }
            },
            "secId": "s0075",
            "sentence": "Similarly, several studies have shown that maternally transferred diphtheria antibodies can interfere with diphtheria and diphtheria-derived CRM-conjugated pneumococcal vaccine responses to the infant primary series following Tdap immunization during pregnancy [4,5,10,21,22,37].",
            "startOffset": 44106,
            "title": "Discussion"
        },
        {
            "endOffset": 28504,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The centers\u2019 Institutional Review Boards and/or Ethics Committees (Supplementary material) approved the protocol, informed consent form and other study-related documents.",
            "startOffset": 28334,
            "title": "Study design and participants"
        },
        {
            "endOffset": 49608,
            "parents": [],
            "secId": "s0085",
            "sentence": "BAN, FMT, FOT, GVZ, JGS, JMMA, JTRA, LK, MAC, MB, MJCO, MMV, MV, NMes, NMey, OGV, PGM, PM, SAH, TN and ZS performed the study and participated in data collection.",
            "startOffset": 49446,
            "title": "Contributors"
        },
        {
            "endOffset": 47099,
            "parents": [],
            "secId": "s0075",
            "sentence": "The current study has several potential limitations.",
            "startOffset": 47047,
            "title": "Discussion"
        },
        {
            "endOffset": 48768,
            "parents": [],
            "secId": "s0080",
            "sentence": "The clinical significance of this interference remains unknown in the absence of a correlate of protection.",
            "startOffset": 48661,
            "title": "Conclusion"
        },
        {
            "endOffset": 32086,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0150": {
                    "endOffset": 32038,
                    "startOffset": 32034
                }
            },
            "secId": "s0020",
            "sentence": "Anti-poliovirus types 1, 2 and 3 antibodies were measured using a validated microneutralization test [30], with antibody titers \u22658 considered protective.",
            "startOffset": 31933,
            "title": "Procedures"
        },
        {
            "endOffset": 47506,
            "parents": [],
            "secId": "s0075",
            "sentence": "In addition, analyses were descriptive with no adjustment for multiplicity.",
            "startOffset": 47431,
            "title": "Discussion"
        },
        {
            "endOffset": 35816,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The primary immunogenicity analyses were performed on the according-to-protocol (ATP) cohort for immunogenicity, including all eligible participants who received at least 1 dose of the study vaccines per protocol, complied with study procedures and intervals, were born full term (\u226537 weeks\u2019 gestation) and had immunogenicity results available for at least one of the study vaccines\u2019 antigens.",
            "startOffset": 35423,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 47047,
            "parents": [],
            "secId": "s0075",
            "sentence": "Hence, the safety profile of DTaP-HepB-IPV/Hib and PCV13 in infants did not change depending on whether their mothers received Tdap during pregnancy.",
            "startOffset": 46898,
            "title": "Discussion"
        },
        {
            "endOffset": 32772,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "All assays were performed at GSK, Rixensart/Wavre, Belgium.",
            "startOffset": 32713,
            "title": "Procedures"
        },
        {
            "endOffset": 46897,
            "parents": [],
            "secId": "s0075",
            "sentence": "SAEs were not reported more frequently in the Tdap group compared to the control group.",
            "startOffset": 46810,
            "title": "Discussion"
        },
        {
            "endOffset": 36870,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "All endpoints were descriptive.",
            "startOffset": 36839,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 37603,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Most infants (~88%) received a 3-dose primary DTaP-HepB-IPV/Hib schedule (mainly at 2, 4 and 6 months of age); of those who received a 2-dose primary schedule, nearly all received their doses at 3 and 5 months of age (Table 1).",
            "startOffset": 37376,
            "title": "Study population"
        },
        {
            "endOffset": 36510,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The primary safety analyses were performed on the total vaccinated cohort (TVC), including all participants who received at least 1 study vaccine dose.",
            "startOffset": 36359,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 35116,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Secondary immunogenicity objectives were to assess antibody concentrations or titers against all DTaP-HepB-IPV/Hib antigens, seropositivity for pertussis, and serotype-specific anti-pneumococcal antibody concentrations 1 month after the last DTaP-HepB-IPV/Hib primary dose; and the persistence of maternally transferred antibodies to all Tdap antigens in terms of concentrations and seroprotection/seropositivity before the first DTaP-HepB-IPV/Hib infant primary dose.",
            "startOffset": 34648,
            "title": "Objectives"
        },
        {
            "endOffset": 45028,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 45027,
                    "startOffset": 45023
                }
            },
            "secId": "s0075",
            "sentence": "This meta-analysis showed that pre-existing antibodies inhibit infant immune responses to primary immunization for 20 of 21 measured antigens, and this in the absence of maternal vaccination [38].",
            "startOffset": 44832,
            "title": "Discussion"
        },
        {
            "endOffset": 36359,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "We also performed exploratory subgroup analyses by dose schedule (2-dose vs 3-dose primary schedule).",
            "startOffset": 36258,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 48404,
            "parents": [],
            "secId": "s0080",
            "sentence": "Our study is the largest RCT to date providing evidence that immunization against pertussis during pregnancy leads to high levels of pertussis antibodies in young infants that persist until the start of the primary immunization series.",
            "startOffset": 48169,
            "title": "Conclusion"
        },
        {
            "endOffset": 43077,
            "parents": [],
            "secId": "s0075",
            "sentence": "There was no evidence of maternally derived antibodies interfering with the infant immune response to tetanus, hepatitis B, poliovirus or Hib PRP in terms of seroprotection rates and GMCs after the primary DTaP-HBV-IPV/Hib series.",
            "startOffset": 42847,
            "title": "Discussion"
        },
        {
            "endOffset": 45761,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 45760,
                    "startOffset": 45757
                }
            },
            "secId": "s0075",
            "sentence": "A recent RCT in the Netherlands investigated the effect of maternal Tdap immunization on pertussis antibody responses of infants starting primary vaccination at 3 months (instead of 2 months) and still found significant blunting [8].",
            "startOffset": 45528,
            "title": "Discussion"
        },
        {
            "endOffset": 40089,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0065",
            "sentence": "We evaluated the immune response to the DTaP-HepB-IPV/Hib and PCV13 primary series separately in infants who received a 2-dose schedule (nearly all at 3 and 5 months of age) and in infants who received a 3-dose schedule (predominantly at 2, 4 and 6 months of age).",
            "startOffset": 39825,
            "title": "Subgroup analysis by dose schedule"
        },
        {
            "endOffset": 27241,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 27240,
                    "startOffset": 27233
                },
                "b0060": {
                    "endOffset": 27240,
                    "startOffset": 27233
                },
                "b0065": {
                    "endOffset": 27240,
                    "startOffset": 27233
                },
                "b0070": {
                    "endOffset": 27240,
                    "startOffset": 27233
                },
                "b0075": {
                    "endOffset": 27240,
                    "startOffset": 27233
                },
                "b0080": {
                    "endOffset": 27240,
                    "startOffset": 27233
                },
                "b0085": {
                    "endOffset": 27240,
                    "startOffset": 27233
                },
                "b0090": {
                    "endOffset": 27240,
                    "startOffset": 27233
                },
                "b0095": {
                    "endOffset": 27240,
                    "startOffset": 27233
                }
            },
            "secId": "s0005",
            "sentence": "This maternal immunization strategy has been observed to provide 69%\u201393% effectiveness against pertussis disease in the first 2 or 3 months of life [11\u201319].",
            "startOffset": 27085,
            "title": "Introduction"
        },
        {
            "endOffset": 27085,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 27084,
                    "startOffset": 27078
                },
                "b0025": {
                    "endOffset": 27084,
                    "startOffset": 27078
                },
                "b0030": {
                    "endOffset": 27084,
                    "startOffset": 27078
                },
                "b0035": {
                    "endOffset": 27084,
                    "startOffset": 27078
                },
                "b0040": {
                    "endOffset": 27084,
                    "startOffset": 27078
                },
                "b0045": {
                    "endOffset": 27084,
                    "startOffset": 27078
                },
                "b0050": {
                    "endOffset": 27084,
                    "startOffset": 27078
                }
            },
            "secId": "s0005",
            "sentence": "Randomized controlled trials (RCTs) and prospective cohort studies have provided evidence that adult-formulation diphtheria-tetanus-acellular pertussis (Tdap) immunization during the second or third trimester of pregnancy results in high levels of pertussis antibodies in cord blood [4\u201310].",
            "startOffset": 26795,
            "title": "Introduction"
        },
        {
            "endOffset": 45527,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 45526,
                    "startOffset": 45522
                }
            },
            "secId": "s0075",
            "sentence": "Given that maternal antibodies decline rapidly over the first months of life, mathematical modeling indicated that the inhibitory effect of a 2-fold to 5-fold increase in maternal antibody concentrations in infants can be offset by a delay of 2.2\u20135.0 weeks in starting primary vaccination [38].",
            "startOffset": 45233,
            "title": "Discussion"
        },
        {
            "endOffset": 30069,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The study had an open-label design because all infants received the same vaccines, but investigators and study staff involved in the infants\u2019 care and responsible for evaluating the study endpoints and laboratory testing remained blinded to the treatment allocation of the infants\u2019 mothers.",
            "startOffset": 29779,
            "title": "Study design and participants"
        },
        {
            "endOffset": 33373,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "SAEs were collected from the first DTaP-HepB-IPV/Hib dose until study end.",
            "startOffset": 33299,
            "title": "Procedures"
        },
        {
            "endOffset": 44105,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 44104,
                    "startOffset": 44090
                },
                "b0025": {
                    "endOffset": 44104,
                    "startOffset": 44090
                },
                "b0030": {
                    "endOffset": 44104,
                    "startOffset": 44090
                },
                "b0050": {
                    "endOffset": 44104,
                    "startOffset": 44090
                },
                "b0105": {
                    "endOffset": 44104,
                    "startOffset": 44090
                },
                "b0110": {
                    "endOffset": 44104,
                    "startOffset": 44090
                }
            },
            "secId": "s0075",
            "sentence": "However, this effect was not consistently observed [4\u20136,10,21,22].",
            "startOffset": 44039,
            "title": "Discussion"
        },
        {
            "endOffset": 38237,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0050",
            "sentence": "Vaccine response rates against the three pertussis antigens were lower in the Tdap than in the control group (39.6% vs 94.8% for anti-FHA, 37.5% vs 90.0% for anti-PRN and 77.1% vs 99.2% for anti-PT; Table 3).",
            "startOffset": 38029,
            "title": "Response to the DTaP-HepB-IPV/Hib primary series"
        },
        {
            "endOffset": 28164,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "This phase IV, multi-center, open-label, non-randomized trial with two parallel groups was conducted between 22 January 2016 and 7 March 2018 in Australia, Canada, Czech Republic, Finland, Italy and Spain.",
            "startOffset": 27959,
            "title": "Study design and participants"
        },
        {
            "endOffset": 29778,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 29777,
                    "startOffset": 29773
                }
            },
            "secId": "s0015",
            "sentence": "The infants\u2019 group allocation was determined by the intervention their mothers received during pregnancy (Tdap or placebo) in the maternal immunization trial [24].",
            "startOffset": 29615,
            "title": "Study design and participants"
        },
        {
            "endOffset": 48660,
            "parents": [],
            "secId": "s0080",
            "sentence": "These high levels of maternal pertussis antibodies can help to further close the susceptibly gap to severe pertussis disease and death in young infants but appear to interfere with the infant\u2019s immune response to the primary pertussis immunization series.",
            "startOffset": 48405,
            "title": "Conclusion"
        },
        {
            "endOffset": 49174,
            "parents": [],
            "secId": "s0080",
            "sentence": "We found no evidence of maternally derived antibodies to Tdap antigens interfering with the infant immune response to tetanus, hepatitis B, poliovirus or Hib PRP and only minimal potential interference with the response to diphtheria and two pneumococcal serotypes.",
            "startOffset": 48909,
            "title": "Conclusion"
        },
        {
            "endOffset": 50053,
            "parents": [],
            "secId": "s0090",
            "sentence": "This work was supported by GlaxoSmithKline Biologicals S.A., which was the funding source, was involved in all stages of the study conduct and analysis and paid for all costs associated with the development and publishing of this manuscript.",
            "startOffset": 49812,
            "title": "Funding"
        },
        {
            "endOffset": 39173,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0055",
            "sentence": "Serotype-specific antibody GMCs were in the same range in both groups for most PCV13 serotypes; minimal differences in GMCs were observed for serotypes 4 and 19F (marginally lower in the Tdap group) (Table 4).",
            "startOffset": 38964,
            "title": "Response to the PCV13 primary series"
        },
        {
            "endOffset": 49805,
            "parents": [],
            "secId": "s0085",
            "sentence": "KPP wrote the manuscript and all authors have revised and approved the manuscript.",
            "startOffset": 49723,
            "title": "Contributors"
        },
        {
            "endOffset": 41242,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The difference between the two groups mainly resulted from a greater number of respiratory tract and other infections reported as SAE in the control compared to the Tdap group (15 vs 2) (Supplementary table 4).",
            "startOffset": 41032,
            "title": "Reactogenicity and safety"
        },
        {
            "endOffset": 43451,
            "parents": [],
            "secId": "s0075",
            "sentence": "The minimal GMC differences observed for serotypes 4 and 19F between the two groups may be explained by the absence of statistical adjustments for multiple testing.",
            "startOffset": 43287,
            "title": "Discussion"
        },
        {
            "endOffset": 44612,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 44426,
                    "startOffset": 44415
                },
                "b0025": {
                    "endOffset": 44426,
                    "startOffset": 44415
                },
                "b0105": {
                    "endOffset": 44426,
                    "startOffset": 44415
                },
                "b0110": {
                    "endOffset": 44426,
                    "startOffset": 44415
                }
            },
            "secId": "s0075",
            "sentence": "In contrast to other studies [4,5,21,22] we did not see an enhancement of the immune response to tetanus post-primary series, despite higher pre-primary anti-tetanus GMCs in infants of Tdap-vaccinated mothers than in controls.",
            "startOffset": 44386,
            "title": "Discussion"
        },
        {
            "endOffset": 41339,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "One infant in the Tdap group was withdrawn due to SAEs (intestinal hemorrhage and milk allergy).",
            "startOffset": 41243,
            "title": "Reactogenicity and safety"
        },
        {
            "endOffset": 27503,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 27502,
                    "startOffset": 27488
                },
                "b0025": {
                    "endOffset": 27502,
                    "startOffset": 27488
                },
                "b0030": {
                    "endOffset": 27502,
                    "startOffset": 27488
                },
                "b0035": {
                    "endOffset": 27502,
                    "startOffset": 27488
                },
                "b0040": {
                    "endOffset": 27502,
                    "startOffset": 27488
                },
                "b0050": {
                    "endOffset": 27502,
                    "startOffset": 27488
                },
                "b0100": {
                    "endOffset": 27502,
                    "startOffset": 27488
                },
                "b0105": {
                    "endOffset": 27502,
                    "startOffset": 27488
                },
                "b0110": {
                    "endOffset": 27502,
                    "startOffset": 27488
                },
                "b0115": {
                    "endOffset": 27502,
                    "startOffset": 27488
                }
            },
            "secId": "s0005",
            "sentence": "However, several studies have raised concerns that transplacentally acquired antibodies could interfere with the infant\u2019s immune response to pertussis and other antigens in the primary infant series (i.e., immunological interference or blunting) [4\u20138,10,20\u201323].",
            "startOffset": 27242,
            "title": "Introduction"
        },
        {
            "endOffset": 38028,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0050",
            "sentence": "The percentages of infants who reached the seroprotective thresholds for anti-diphtheria, anti-tetanus, anti-HBs, anti-poliovirus types 1\u20133 and anti-PRP 1 month post-primary vaccination were similar between groups: 100% in both groups for anti-diphtheria and anti-tetanus, \u226598.5% for anti-HBs, \u226595.9% for anti-poliovirus and \u226594.5% for anti-PRP (Table 2).",
            "startOffset": 37673,
            "title": "Response to the DTaP-HepB-IPV/Hib primary series"
        },
        {
            "endOffset": 31603,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 31602,
                    "startOffset": 31595
                },
                "b0130": {
                    "endOffset": 31602,
                    "startOffset": 31595
                }
            },
            "secId": "s0020",
            "sentence": "Seroprotection for diphtheria and tetanus was defined as an antibody concentration \u22650.1 IU/mL [25,26].",
            "startOffset": 31501,
            "title": "Procedures"
        },
        {
            "endOffset": 30782,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "PCV13 contains capsular polysaccharides of 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9 V, 14, 18C, 19A, 19F and 23), each conjugated to the diphtheria toxoid variant CRM197.",
            "startOffset": 30600,
            "title": "Procedures"
        },
        {
            "endOffset": 31671,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 31670,
                    "startOffset": 31666
                }
            },
            "secId": "s0020",
            "sentence": "No correlate of protection has been established for pertussis [27].",
            "startOffset": 31604,
            "title": "Procedures"
        },
        {
            "endOffset": 39786,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0060",
            "sentence": "Antibody GMCs at the pre-primary time point in the Tdap group were significantly higher than those in the control group for all Tdap antigens (Table 5).",
            "startOffset": 39634,
            "title": "Persistence of maternally transferred antibodies to Tdap antigens"
        },
        {
            "endOffset": 41427,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "No SAEs were deemed related to infant vaccination and no infants died during the study.",
            "startOffset": 41340,
            "title": "Reactogenicity and safety"
        },
        {
            "endOffset": 46578,
            "parents": [],
            "secId": "s0075",
            "sentence": "However, this requires ongoing monitoring.",
            "startOffset": 46536,
            "title": "Discussion"
        },
        {
            "endOffset": 26618,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 26617,
                    "startOffset": 26612
                },
                "b0010": {
                    "endOffset": 26617,
                    "startOffset": 26612
                }
            },
            "secId": "s0005",
            "sentence": "Despite comprehensive global infant immunization programs, pertussis (Bordetella pertussis) continues to cause high morbidity and mortality among infants <2 months of age who are too young to be vaccinated [1,2].",
            "startOffset": 26406,
            "title": "Introduction"
        },
        {
            "endOffset": 32514,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0165": {
                    "endOffset": 32513,
                    "startOffset": 32509
                }
            },
            "secId": "s0020",
            "sentence": "Serotype-specific anti-pneumococcal capsular polysaccharide antibodies (for the PCV13 serotypes) were measured using validated multiplex electrochemiluminescence (ECL) assays [33].",
            "startOffset": 32334,
            "title": "Procedures"
        },
        {
            "endOffset": 38519,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0050",
            "sentence": "One month post-primary vaccination, all infants in the Tdap group were seropositive for all pertussis antibodies but antibody GMCs were lower in the Tdap than in the control group (68.5 vs 103.5 IU/mL for anti-FHA, 60.5 vs 92.0 for anti-PRN, and 32.7 vs 54.7 for anti-PT; Table 3).",
            "startOffset": 38238,
            "title": "Response to the DTaP-HepB-IPV/Hib primary series"
        },
        {
            "endOffset": 33705,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The investigators assessed the intensity of all AEs and their causal relation to infant vaccination.",
            "startOffset": 33605,
            "title": "Procedures"
        },
        {
            "endOffset": 33766,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Solicited local AEs were all considered vaccination-related.",
            "startOffset": 33706,
            "title": "Procedures"
        },
        {
            "endOffset": 40313,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "Immunogenicity"
                }
            ],
            "secId": "s0065",
            "sentence": "However, interpretation of these results is limited by the small sample size of the 2-dose subgroup.",
            "startOffset": 40213,
            "title": "Subgroup analysis by dose schedule"
        },
        {
            "endOffset": 31932,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 31931,
                    "startOffset": 31924
                },
                "b0140": {
                    "endOffset": 31931,
                    "startOffset": 31924
                },
                "b0145": {
                    "endOffset": 31931,
                    "startOffset": 31924
                }
            },
            "secId": "s0020",
            "sentence": "Anti-hepatitis B surface antigen (HBs) antibodies were measured using a commercial chemiluminescence immunoassay (ADVIA Centaur anti-HBs2, Siemens Healthcare) with an assay cut-off of 6.2 mIU/mL and a concentration of 10 mIU/mL defining seroprotection [27\u201329].",
            "startOffset": 31672,
            "title": "Procedures"
        },
        {
            "endOffset": 44038,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 44037,
                    "startOffset": 44023
                },
                "b0025": {
                    "endOffset": 44037,
                    "startOffset": 44023
                },
                "b0030": {
                    "endOffset": 44037,
                    "startOffset": 44023
                },
                "b0035": {
                    "endOffset": 44037,
                    "startOffset": 44023
                },
                "b0040": {
                    "endOffset": 44037,
                    "startOffset": 44023
                },
                "b0050": {
                    "endOffset": 44037,
                    "startOffset": 44023
                },
                "b0100": {
                    "endOffset": 44037,
                    "startOffset": 44023
                },
                "b0105": {
                    "endOffset": 44037,
                    "startOffset": 44023
                },
                "b0110": {
                    "endOffset": 44037,
                    "startOffset": 44023
                }
            },
            "secId": "s0075",
            "sentence": "Previous studies assessing the administration of Tdap vaccines (three- or five-component pertussis vaccines) during pregnancy have reported significantly lower antibody responses to one or more pertussis antigens in infants born to Tdap-vaccinated mothers following completion of their primary series compared to infants whose mothers had not been Tdap-vaccinated [4\u20138,10,20\u201322].",
            "startOffset": 43659,
            "title": "Discussion"
        },
        {
            "endOffset": 28579,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "An independent data monitoring committee oversaw the participants\u2019 safety.",
            "startOffset": 28505,
            "title": "Study design and participants"
        },
        {
            "endOffset": 32333,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0155": {
                    "endOffset": 32332,
                    "startOffset": 32325
                },
                "b0160": {
                    "endOffset": 32332,
                    "startOffset": 32325
                }
            },
            "secId": "s0020",
            "sentence": "Anti-Hib polyribosylribitol phosphate (PRP) antibodies were measured using a validated ELISA, with an assay cut-off of 0.066 \u00b5g/mL and concentrations of 0.15 \u00b5g/mL and 1.0 \u00b5g/mL indicative of short- and long-term protection, respectively [31,32].",
            "startOffset": 32087,
            "title": "Procedures"
        },
        {
            "endOffset": 40640,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Most solicited AEs in both groups were mild or moderate.",
            "startOffset": 40584,
            "title": "Reactogenicity and safety"
        },
        {
            "endOffset": 35422,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The sample size was based on the number of mothers enrolled in the maternal immunization trial.",
            "startOffset": 35327,
            "title": "Statistical analyses"
        },
        {
            "endOffset": 47270,
            "parents": [],
            "secId": "s0075",
            "sentence": "It was conducted in six high-income countries, and participants of the original study (NCT02377349) were mainly white Caucasian women and women with low-risk pregnancies.",
            "startOffset": 47100,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X19315063",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "kirsten.perrett@rch.org.au",
                "first": "Kirsten P.",
                "initial": "K.P.",
                "last": "Perrett"
            },
            {
                "email": "scott.halperin@dal.ca",
                "first": "Scott A.",
                "initial": "S.A.",
                "last": "Halperin"
            },
            {
                "email": "t.nolan@unimelb.edu.au",
                "first": "Terry",
                "initial": "T.",
                "last": "Nolan"
            },
            {
                "email": "alfonsocarmona@ihppediatria.com",
                "first": "Alfonso",
                "initial": "A.",
                "last": "Carmona Mart\u00ednez"
            },
            {
                "email": "federico.martinon.torres@sergas.es",
                "first": "Federico",
                "initial": "F.",
                "last": "Martin\u00f3n-Torres"
            },
            {
                "email": "jgarcia-sicilia@telefonica.net",
                "first": "Jose",
                "initial": "J.",
                "last": "Garc\u00eda-Sicilia"
            },
            {
                "email": "miia.virta@staff.uta.fi",
                "first": "Miia",
                "initial": "M.",
                "last": "Virta"
            },
            {
                "email": "ovanderk@ucalgary.ca",
                "first": "Otto G.",
                "initial": "O.G.",
                "last": "Vanderkooi"
            },
            {
                "email": "gianvincenzo.zuccotti@unimi.it",
                "first": "Gian Vincenzo",
                "initial": "G.V.",
                "last": "Zuccotti"
            },
            {
                "email": null,
                "first": "Paolo",
                "initial": "P.",
                "last": "Manzoni"
            },
            {
                "email": "lusine.x.kostanyan@gsk.com",
                "first": "Lusine",
                "initial": "L.",
                "last": "Kostanyan"
            },
            {
                "email": "nadia.x.meyer@gsk.com",
                "first": "Nadia",
                "initial": "N.",
                "last": "Meyer"
            },
            {
                "email": "maria-angeles.x.ceregido@gsk.com",
                "first": "Maria Angeles",
                "initial": "M.A.",
                "last": "Ceregido"
            },
            {
                "email": "brigitte.cheuvart@gsk.com",
                "first": "Brigitte",
                "initial": "B.",
                "last": "Cheuvart"
            },
            {
                "email": "sherine.o.kuriyakose@gsk.com",
                "first": "Sherine O.",
                "initial": "S.O.",
                "last": "Kuriyakose"
            },
            {
                "email": "z.stranak@seznam.cz",
                "first": "Zbynek",
                "initial": "Z.",
                "last": "Stranak"
            },
            {
                "email": null,
                "first": "Jose M.",
                "initial": "J.M.",
                "last": "Merino Arribas"
            },
            {
                "email": "mjose.cilleruelo@salud.madrid.org",
                "first": "Mar\u00eda Jos\u00e9",
                "initial": "M.J.",
                "last": "Cilleruelo Ortega"
            },
            {
                "email": "mariano.miranda@andaluciajunta.es",
                "first": "Mariano",
                "initial": "M.",
                "last": "Miranda-Valdivieso"
            },
            {
                "email": "barias@sanitas.es",
                "first": "Bego\u00f1a",
                "initial": "B.",
                "last": "Arias Novas"
            },
            {
                "email": "josetomas.ramos@salud.madrid.org",
                "first": "Jose Tomas",
                "initial": "J.T.",
                "last": "Ramos Amador"
            },
            {
                "email": null,
                "first": "Felix",
                "initial": "F.",
                "last": "Ome\u00f1aca"
            },
            {
                "email": "pediatra@manuelbaca.com",
                "first": "Manuel",
                "initial": "M.",
                "last": "Baca"
            },
            {
                "email": "paola.marchisio@unimi.it",
                "first": "Paola Giovanna",
                "initial": "P.G.",
                "last": "Marchisio"
            },
            {
                "email": "narcisa.x.mesaros@gsk.com",
                "first": "Narcisa",
                "initial": "N.",
                "last": "Mesaros"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.10.104",
        "firstpage": "2105",
        "issn": "0264410X",
        "keywords": [
            "Blunting",
            "Infants",
            "Maternal immunization",
            "Pertussis",
            "Tdap vaccine"
        ],
        "lastpage": "2114",
        "openaccess": "Full",
        "pub_year": 2020,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial"
    }
}